A single dose study of a Prototype MK-0518 formulation(QBR115620)

• Research type

  Research Study

• Full title

  A Product Value Enhancement Single Dose Feasibility Study of a Prototype MK-0518 Gastroretentive Formulation

• IRAS ID

  130095

• Contact name

  Philip Evans

• Contact email

  phil.evans@quotientbioresearch.com

• Sponsor organisation

  Merck, Sharp and Dohme Corp., a subsidiary of Merck & Co., Inc.

• Eudract number

  2013-001158-85

• ISRCTN Number

  to be applied for

• REC name

  Wales REC 2

• REC reference

  13/WA/0147

• Date of REC Opinion

  15 May 2013

• REC opinion

  Further Information Favourable Opinion